We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.2B
AUM Growth
+$195M
Cap. Flow
+$335M
Cap. Flow %
10.47%
Top 10 Hldgs %
21.65%
Holding
6,527
New
499
Increased
2,768
Reduced
2,277
Closed
582

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$63.7M
2
AMZN icon
Amazon
AMZN
+$45.1M
3
AAPL icon
Apple
AAPL
+$36.4M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$32.3M
5
NVDA icon
NVIDIA
NVDA
+$27.2M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$230M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$128M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$70.3M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$28.9M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 24.66%
2 Consumer Discretionary 9.76%
3 Financials 9.58%
4 Healthcare 8.56%
5 Industrials 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNLN icon
4726
Greenlane Holdings
GNLN
$1.24M
– –
0
– –
DCOY
4727
Decoy Therapeutics
DCOY
$2.06M
$5.39K ﹤0.01%
6
– –
EDSA icon
4728
Edesa Biotech
EDSA
$53.2M
$5.38K ﹤0.01%
1,217
– –
AREB
4729
DELISTED
American Rebel
AREB
– –
0
– –
MFM
4730
Aberdeen Municipal Income Fund
MFM
$222M
$5.37K ﹤0.01%
+1,181
New +$5.93K
AQB icon
4731
AquaBounty Technologies
AQB
$7.67M
$5.36K ﹤0.01%
1,121
-680
-38% -$4.02K
TMBR
4732
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$5.35K ﹤0.01%
1,797
-1,127
-39% -$2.63K
PBHC icon
4733
Pathfinder Bancorp
PBHC
$102M
$5.34K ﹤0.01%
404
-311
-43% -$4.32K
UIS icon
4734
Unisys
UIS
$205M
$5.33K ﹤0.01%
1,544
-7,175
-82% -$30.3K
DVAL icon
4735
BrandywineGLOBAL Dynamic US Large Cap Value ETF
DVAL
$80.7M
$5.33K ﹤0.01%
459
+397
+640% +$4.74K
TCRT icon
4736
Alaunos Therapeutics
TCRT
$4.81M
$5.33K ﹤0.01%
269
+147
+120% +$6.33K
AUMN
4737
DELISTED
Golden Minerals Company
AUMN
$5.33K ﹤0.01%
8,334
+8,204
+6,311% +$8.49K
TERN
4738
DELISTED
Terns Pharmaceuticals
TERN
$5.3K ﹤0.01%
1,054
-6,957
-87% -$44.1K
MOVE icon
4739
Corvex Inc
MOVE
$304M
$5.3K ﹤0.01%
44
-24
-35% -$3.26K
BMRA icon
4740
Biomerica
BMRA
$4.85M
$5.29K ﹤0.01%
770
+36
+5% +$357
TRNR icon
4741
Interactive Strength
TRNR
$1.76M
– –
0
– –
CITE
4742
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$5.27K ﹤0.01%
489
+244
+100% +$2.61K
VIRX
4743
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$5.26K ﹤0.01%
5,059
+17
+0.3% +$23
AGRX
4744
DELISTED
Agile Therapeutics
AGRX
$5.26K ﹤0.01%
2,191
-521
-19% -$1.28K
MPTI icon
4745
M-tron Industries
MPTI
$370M
$5.24K ﹤0.01%
296
-987
-77% -$14.8K
EHTH icon
4746
eHealth
EHTH
$39.1M
$5.21K ﹤0.01%
704
-3,721
-84% -$29.2K
PXLW icon
4747
Pixelworks
PXLW
$38.3M
$5.19K ﹤0.01%
383
+43
+13% +$742
SIEB icon
4748
Siebert Financial
SIEB
$68.8M
$5.19K ﹤0.01%
2,661
+148
+6% +$330
FPF
4749
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
$5.18K ﹤0.01%
+348
New +$5.31K
FIEE
4750
FiEE Inc
FIEE
$32.4M
$5.18K ﹤0.01%
3,574
+2,439
+215% +$6.56K
188 189
190
191 192

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2023 Portfolio in Review

As of Q3 2023, Tower Research Capital (TRC) held 6,527 positions worth $3.2B, up 6.5% from $3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC) deployed $335M of net new capital in Q3 2023, opening 499 new positions and adding to 2,768 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 64,943 shares worth $14.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $230M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2023 buy was iShares Russell 2000 Growth ETF: 64,943 shares worth $14.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q3 2023, an estimated $63.7M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $230M.
  • Tower Research Capital (TRC) fully exited PDC Energy, Inc. in Q3 2023, selling an estimated $2.65M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.2B portfolio in Q3 2023.
  • Tower Research Capital (TRC) opened 499 new positions and closed 582 in Q3 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 6.5% quarter-over-quarter to $3.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.